It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
The Obama administration is weeks away from a critical decision on whether to trigger mass production of swine-flu vaccine, which could affect the bottom lines of big vaccine makers as well as public health.
Besides determining whether a vaccine would be effective and safe, government officials and private laboratories will need to answer practical and financial questions: Does it make sense to order hundreds of millions of doses and organize a mass vaccination campaign for a virus that, so far, isn't widespread and doesn't seem particularly lethal?